(Q33913195)

30 July 2017

1 reference

title

Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient (English)

1 reference

30 July 2017

1 reference

Boucher BA

1

1 reference

PubMed ID

10802265

30 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

The American Journal of Surgery

30 July 2017

1 reference

30 July 2017

179

1 reference

30 July 2017

45S-50S

1 reference

30 July 2017

2A Suppl

1 reference

Carbapenems and monobactams: imipenem, meropenem, and aztreonam

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Metabolism and pharmacokinetics of aztreonam in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Nephrotoxicity and ototoxicity of aztreonam versus aminoglycoside therapy in seriously ill nonneutropenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

New intervention strategies for reducing antibiotic resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

What is the cost of nephrotoxicity associated with aminoglycosides?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Safety profile of aztreonam in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2800%2900321-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9610(00)00321-4

1 reference

30 July 2017

1 reference